Interactions of the Platinum(II) Complexes with Nitrogen- and Sulfur-Bonding Bio-Molecules in Chronic Lymphocytic Leukemia by Jovana Bogojeski et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
16 
Interactions of the Platinum(II) Complexes with 
Nitrogen- and Sulfur-Bonding Bio-Molecules in 
Chronic Lymphocytic Leukemia 
Jovana Bogojeski, Biljana Petrović and Živadin D. Bugarčić*  
University of Kragujevac, Faculty of Science, Department of Chemistry 
Serbia 
1. Introduction 
Transition metals and their reactions are in general important in the environment, in 
technical processes (catalysis, extraction and purification of metal complexes) and in biology 
and medicine (biological electron transfer, toxicology and use of metal complexes as drugs). 
Moreover, nonessential metal ions are very often used in biological systems either for 
therapeutic application or as diagnostic aids. For instance, metal complexes have been used 
for the treatment of many diseases (cancer, arthritis, diabetes, Alzheimer, etc.), but with little 
understanding of their mechanism of action in biological systems.(Ronconi & Sadler, 2007; 
Bruijnincx & Sadler, 2009) Biochemical studies have not clearly established the molecular 
basis for the activity and mechanism of action. The growing field of bioinorganic chemistry 
is presently dealing with the clarification of the mechanisms of action of metal complexes in 
biological systems.(Ronconi & Sadler,2007; Bruijnincx & Sadler, 2009; Jakupec et al., 2008) 
Research in the area of application of metal complex compounds in medicine began with the 
discovery of antitumor properties of cisplatin. (Rosenberg, 1965, 1967, 1969, 1970) Today 
cisplatin is in routine use as therapeutics worldwide. Following the success of cisplatin a 
large number of analogous compounds were synthesized. All these compounds have a 
several common characteristics: 
1. bifunctional complex compounds with cis-geometry 
2. PtX2(amin)2 is general formula of this compounds, where X2 are two labile monodentate 
or one labile bidentate ligand, and (amine)2 are inert nitrogen-donor ligands 
3. nitrogen-donor ligands have to containe at least one NH bond. 
Despite the large number of synthesized compounds only a few of them entered the 
medicinal use and most are still in preclinical investigation. (Jakupec et al., 2003; Reedijk, 
2009) At the Fig. 1. are presented some of platinum complexes that are in the medicinal use 
worldwide.   
Chronic lymphocytic leukemia is the most frequent type of leukemia and it accounts for 
approximately 25% of all leukemias. (Chiorazzi et al., 2005) Although at the present there is 
no curative treatment, combinations of cytotoxic agents and of immunotherapies that 
generate high complete remission rates hold promise for altering the natural history of this 
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disease. (Wierda et al., 2005) Fludarabine (9-beta-D-arabinofuranosyl-2-fluoroadenine 5’-
phosphate) is the most effective purine nucleoside analogue for the treatment of indolent 
lymphoproliferative disorders, including Chronic lymphocytic leukemia, low-grade 
lymphoma, and prolymphocytic leukemia. (Eichhorst et al., 2005) 
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Fig. 1. The structures of some platinum complexes which are in clinical use worldwide. 
The studies show that among the best drugs in the treatment of Chronic lymphocytic 
leukemia are the combination of Pt(II) complexes (cisplatin and oxaliplatin) and alkylating 
agents and nucleoside analogues such as fluradabine. (Zecevic et al., 2011) The 
nonoverlapping side effect profiles of oxaliplatin and fludarabine and their different but 
potentially complementary mechanisms of action provide a basis for investigation of the 
activity of the drugs in combination. The rationale for combining oxaliplatin with 
fludarabine is based on preclinical data showing synergistic cytotoxicity between cisplatin 
in combination with the nucleoside. (Wang et al., 1991; Yamauchi et al., 2001) 
Consequently, knowledge of the interaction of the different Pt(II) complexes and  nitrogen- 
and sulfur-bonding bio-molecules, and the results obtained from in vitro studies of this type 
of interactions will help in finding of good antitumor drug for the treatment of many tumors 
including the Chronic lymphocytic leukemia. The main topic of this chapter will be to show 
the results obtained in numerous studies of the interactions of the potential antitumor Pt(II) 
complexes and different biomolecules. 
Platinum(II) has a high affinity for sulphur, so after administrating  Pt(II) complex in the 
human body there is a strong possibility for binding with sulphur-donor bio-molecules. 
Sulphur-donor bio-molecules are present in large amounts in the form of peptides, proteins 
and enzymes. Binding of platinum complexes with sulphur-donor bio-molecules are 
responsible for the occurrence of toxic effects. (Lippert, 1999; Reedijk, 1999) However, a 
certain amount of platinum complexes being bound to nitrogen-donor bio-molecules (amino 
acids or DNA). Today it is generally accepted that the anti-tumor activity of platinum drugs 
can be ascribed to interactions between the metal complex and DNA, primarily with the 
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genetic DNA, which is located in the nucleus. The interactions with mitochondrial DNA are 
less responsible for the antitumor activity of the platinum complexes. (Fuertes et al., 2003) 
When the Pt(II) complexe reach the DNA, the possibilities for coordination are different. 
Binding of Pt(II) complexes to DNA primarily occurs through the N7 atoms of guanine, 
while a binding to N7 and N1 of adenine and N3 of cytosine occurs in small amount. 
(Lippert, 1999; Reedijk, 1999) Since the DNA molecule containing a different sequence of 
purine and pyrimidine bases, it was found that with 60% represented the coordination of 
the type 1,2-(GPG), i.e., the coordination realizes via two molecules of guanosine-5’-
monophosphate (5’-GMP), which are located on opposite strands of DNA. About 25% is 
represented by coordination of the type 1,2-(APG), i.e. coordination with adenosine-5'-
monophosphate (5’-AMP) and 5’-GMP placed on opposite DNA strands. Other ways of 
coordinations (monofunctional binding of the type 1,3-(GPG), coordination via guanosine 
located on the same chain of DNA, etc.) are less frequent. On the Fig. 2. is shown the 
different ways of coordination of cisplatin to DNA. (Jakupec et al., 2003; Kozelka et al., 1999) 
 
Fig. 2. The different ways of coordinations of cisplatin to DNA. 
However, as noted above, the cells contain other bio-molecules which can also react with 
platinum complexes. High affinities for the platinum complexes show the bio-molecules that 
contain sulphur, as the thiols and the thioethars.  Namely, Pt(II) as "soft" acid forms very stable 
compounds with sulphur donor ("soft" bases). The resulting compounds are responsible for 
the occurrence of toxicity (nephrotoxicity, neurotoxicity, resistance, etc.). Since the 
concentration of thiols, including glutathione (GSH) and L-cysteine, in intracellular liquid is 
about 10 mM, it is assumed that most of the platinum complex bound to sulphur before it 
comes to the molecules of DNA. (Jakupec et al., 2003; Reedijk, 2009; Lippert, 1999; Reedijk, 
1999) Binding of platinum complexes to sulphur from thioethars are the kinetically favored 
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process. The resulting Pt-S(thioethar) bond may be terminated in the presence of DNA, i.e. N7 
atom of 5’-GMP can substitute the molecule of thioethar. (Reedijk, 1999; Soldatović & Bugarčić, 
2005) For these reasons the compounds of the type Pt-S(thioethers) are believe to be the 
reservoirs of “platinum complexes’’ in the body, i.e. they are suitable intermediates in the 
reaction of Pt(II) complexes and DNA. Pt-S(thioethers) bond can be terminated in the presence 
of thiol molecules. The product of this substitution is thermodynamically stable. Also, Pt(II) 
complex can direct bind to sulphur from thiol molecules and the resulting Pt-S(thiol) bond is 
very stable and can not be easy broken. It is believed that compounds of the type Pt-S(thiol) 
are responsible for the occurrence of toxic effects during the use of Pt(II) complexes as 
anticancer reagents. The Pt-S(thiol) bond can be terminated in the presents of compounds 
known as "rescue agentsŉ, which are compounds with sulphur and they are very strong 
nucleophiles (diethyldithiocarbamate, thiourea, thiosulfate, GSH, cysteine, biotin, etc.). 
(Jakupec et al., 2003; Fuertes et al., 2003; Soldatović & Bugarčić, 2005) 
 
Scheme 1. Schematic presentation of the levels of action of cisplatin in the cell and possible 
biological consequences. 
In recent years a much attention has given to studies of the antitumor activity of polynuclear 
Pt(II) complexes structurally similar to cisplatin.(Harris et al., 2005) The bridge ligand can be 
diamine ligands of the type NH2(CH2)nNH2 (n = 6). (Mambanda et al., 2010) In the reaction 
with DNA primarily is obtained compound in which complex is bound simultaneously to 
both spirale. (Mambanda et al., 2010; Berners-Price et al., 2003) It was found that the 
presence of the hydrophobic part of the molecule enhances the absorption of these 
compounds on the cell membrane, where their activity decrease. Also, the polynuclear Pt(II) 
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complexes with heterocyclic nitrogen compounds as bridge ligands were synthesized. 
(Lakomska et al., 2009)  
Pt(IV) complexes are also very interesting. They react more slowly than the corresponding 
Pt(II) complexes.(Ali et al., 2005) It assumed that first Pt(IV) complexes by reduction 
translate to Pt(II) complexes  and then the mechanism of action is the same as in the case of 
Pt(II) complexes. (Talman et al., 1997) For the reduction of Pt(IV) complexes can serve GSH, 
L-cysteine, L-methionine, DL-penicilamin (Lemma et al., 2000a) or ascorbic acid. (Lemma et 
al., 2000b) 
Besides the already mentioned complexes of Pt(II), there are other platinum compounds 
such as trans-[PtCl2(NH3)2] which does not show antitumor activity. (Jolley et al., 2001) 
These complexes were also intensively studied, (Natile & Coluccia, 2001)  as well as some 
dinuclear complexes of trans-geometry. (Jansen et al., 2002) Special attention in recent years 
were given to the investigation of dinuclear complexes of platinum and paladium. (Mock et 
al., 2001) 
2. Interaction of monofunctional Pt(II) complexes with sulphur- and nitrogen-
donor bio-molecules 
Monofunctional complexes of Pt(II) are a complexes which in structure contains a stable 
tridentate ligand, while the fourth coordination place is occupied with labile ligand, mostly 
chloride ligand. Because of this structure these complexes are not able to bind bifunctionaly 
to the DNA molecule. Accordingly to this monofunctional complexes of Pt(II) do not exhibit 
antitumor properties. However, one place for coordination greatly simplifies testing of 
substitution reactions of these complexes. For these reasons monofunctional complexes 
present model molecules for the study of interactions of Pt(II)  complexes and bio-molecules 
which contain sulphur- and nitrogen-donor ligands. 
Probably the greatest interest in examining substitution reactions of the monofunctional  
complexes are for complexes of general formula [Pt(NNN)X], where NNN represents a 
tridentate ligand coordinated via three nitrogen donor atoms, while X is a labile ligand, 
usually chlorido ion. Most intensively studied compounds from this group are [Pt(dien)Cl]+, 
where dien is diethylentriamine or 1,5-diamino-3-azapentane, [Pt(bpma)Cl]+, where bpma is 
bis-(2-pyridylmethyl)amine, and [Pt(terpy)Cl]+, where terpy is (2,2ň:6ň,2ŉ-terpyridine).  
2.1 Interaction of [Pt(dien)Cl]+ complex with sulphur- and nitrogen-donor  
bio- molecules 
There are a large number of studies of substitution reactions of the [Pt(dien)Cl]+ complex  
and his aqua analog, with different ligands and in different experimental conditions. This 
studies including investigations of the substitution reactions of the [Pt(dien)Cl]+ complex 
with sulphur-donor ligands, especially with thiols and thioethers and nitrogen-donor 
ligands.  
In the substitution reactions of [Pt(dien)Cl]+ with GSH  it was observed that substitution 
process depends on the pH value at which the reaction is studied. (Đuran et al. 1991; Bose et 
al., 1995; Tauben et al. , 2000; Petrović B. & Bugarčić, 2001) At pH > 7 as the only reaction 
product are obtained mononuclear complexes [Pt(dien)GS]+, while at pH < 7 a binuclear 
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complex [{Pt(dien)2GS}]3+ with GSH as the bridging ligand forms. Also, the process of 
substitution is followed by deprotonation of GSH, which is observed in the reactions of 
other Pt(II) complexes with thiols. (Bugarčić & Đorđević, 1998) When the ligand is thioetar, 
S-methyl-glutathione, reactions are much faster, but the product with thiol is 
thermodynamically more stable. (Tauben et al., 2002) Comparing the values of rate 
constants of substitution reactions of  [Pt(dien)Cl]+  complexes with different thiols and 
thioethers, (Tauben et al. , 2000; Petrović B. & Bugarčić, 2001; Bugarčić & Đorđević, 1998; 
Lampers & Reedijk, 1990) it was noted a discrepancy of GSH compared to other thiols. GSH 
is a tripeptide that contains an unusual peptide linkage between the amine group of  
L-cysteine (which is attached by normal peptide linkage to a L-glycine) and the carboxyl 
group of the glutamate side-chain, with a L-cysteine molecule at the center. It was assumed 
that the substitution process was much slower compared to L-cysteine. However, the 
experimentally obtained values showed a much higher reactivity of GSH. This is explained 
by a suitable geometrical structure of molecules, which cause the formation of 
intramolecular hydrogen bond involving the proton from the thiol groups, resulting in 
significantly increased nucleophelicity of the sulphur atoms and therefore higher reactivity. 
(Bugarčić et al., 2004a;, Petrović B. & Bugarčić, 2001; Bugarčić & Đorđević, 1998) 
During the substitution reaction of the [Pt(dien)Cl]+ complexes with  
L-methionine (Petrović B. & Bugarčić, 2001; Lampers & Reedijk, 1990; Barnham et al. , 1994) 
as a reaction product primarily has been formed complex [Pt(dien)(L-methionine)]2+. It was 
noted that only in very acidic solutions (pH < 1) there is a possibility for protonation of the 
terminal amino groups of dien ligand, which leads to the opening of one chelate ring and the 
creation of S,N-chelat. (Chen et al., 1998) Reaction between [Pt(dien)Cl]+ complexes and L-
methionine was studied in the presence of 5'-GMP, assuming the existence of competition of 
this two ligands.(Lampers & Reedijk, 1990; Soldatović & Bugarčić, 2005) The [Pt(dien)Cl]+  
first reacts with L-methionine and form [Pt(dien)(L-methionine)]2+ product. Then 5'-GMP 
molecule coordinated to Pt(II) by substitution of coordinated L-methionine forming 
thermodynamically more stable [Pt(dien)(N7-GMP)]2+ complex.  
INO, 5’-IMP and 5’-GMP can coordinate to metal ions via N1 and N7. (Arpalahti  & 
Lehikoinen, 1990; Arpalahti & Lippert, 1990; Caradonna & Lippard, 1988; Bose et al., 1986; 
Martin, 1999) Under pH = 2.5 only the N7 position of INO, 5’-IMP and 5’-GMP will be free 
for coordination to the central metal atom, since at this pH the N1 position is protonated. 
(Sigel et al., 1994) Binding through the N7 position in a neutral or weakly acidic medium has 
been verified. (Bugarčić et al., 2004a) 5’-GMP is more reactive toward Pt(II) complexes than 
either INO or 5’-IMP. Furthermore, the pH at which anti-tumor complexes bind to DNA is 
significantly higher than this one. It is expected that at neutral pH the phosphate residue on 
the nucleotide will also bind to the central metal atom as a result of its deprotonation. 
(Jacobs et al., 1992) 
From a comparison of the reactivity of GSH or L-methionine with INO, 5’-IMP and  
5’-GMP in the reaction with [Pt(dien)(H2O)]2+, [Pt(dien)Cl]+ and [Pt(dien)Br]+ (Soldatović & 
Bugarčić, 2005) can be concluded that these N-bonding ligands are good nucleophiles. This 
small difference in the reactivity of N-bondining (INO, 5’-IMP and 5’-GMP) and  
S-bonding nucleophiles (GSH and L-methionine) is not usually. The complex formation 
reactions have been studied at pH 2.5 were GSH and L-methionine are protonated. On the 
other hand, at pH 2.5, N7 sites of N-bonding ligands are not protonated. However, at 
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neutral pH, although less than 10% of thiols are deprotonated, the N-bonding ligand cannot 
compete with the thiols. The second-order rate constant for GSH is 102 times higher than for 
the 5’-GMP. (Bugarčić et al., 2004b) Also, from obtained results, (Soldatović & Bugarčić, 
2005) could be concluded that L-methionine is the best nucleophile for the Pt(II) complexes. 
This could be explaining by positive inductive effect of the methyl group on the sulphur. 
However, this is in agreement with the previous results. (Petrović B. & Bugarčić, 2001) 
Competitive reactions of [Pt(dien)Cl]+ with L-methionine and 5’-GMP demonstrated 
initially rapid formation of [Pt(dien)(L-methionine)]2+ followed by displacement of  
L-methionine by 5’-GMP. In the later stages the concentration of [Pt(dien)(N7-GMP)]2+ is 
predominant. (Soldatović & Bugarčić, 2005) 
The reactions of [Pt(dien)Cl]+ (10 mM) with L-methionine and 5’-GMP in a molar ratio: 
[Pt(dien)Cl]+: L-methionine : 5’-GMP = 1:1:3 were also studied. (Soldatović & Bugarčić, 2005) 
In the initial stage of the reactions (< 40 h) 1H NMR peak for the free L-methionine (d 2.142 
ppm) decrease in the intensity and new peak of the [Pt(dien)(L-methionine)]2+ appeared in 
the spectrum (d 2.544 ppm), whereas a little of the 5’-GMP reacted. In the later stages (72 h), 
the peaks for the bounded L-methionine and free 5’-GMP (d 8.208 ppm) decreased in 
intensity, whereas those for free L-methionine increased in intensity, as did those assignable 
to bound 5’-GMP in [Pt(dien)(N7-GMP)]2+ (d 8.624 ppm) as shown in Fig. 3 
 
 
 
 
 
 
Fig. 3. 1H NMR spectra of the reactions of [Pt(dien)Cl]+ (10 mM) with mixture of   
L-methionine and 5’-GMP in the ratio 1:1:3 (where 1 is the signal for the  [Pt(dien)  
(L-methionineh)]2+, 2 is the signal for the [Pt(dien)(N7-GMP)]2+, 3 is the signal for the free  
L-methionine and 4 is the signal for the free 5’-GMP. (Soldatović & Bugarčić, 2005) 
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Moreover, Pt–thioether adducts are more easily converted into Pt–thiolate adduct than  
Pt–N7–GMP adduct. (Teuben et al., 2000) On the other hand, it has been known that 5’-GMP 
cannot substitute thiols from Pt–thiolate adduct. (Bugarčić et al., 2004a) These findings could 
have implications for the mechanism of action of platinum anticancer drugs. Sulphur-
bonding ligands have a much higher affinity for Pt(II) complexes than nitrogen-bonding 
ligands. (Bugarčić et al., 2004a; Bugarčić et al., 2002a) Moreover, nephrotoxicity has been 
explained by the formation of Pt–S(GSH) aduct. 
Product in reactions of the [Pt(dien)Cl]+ complexes with thioethers or nucleotides in the 
presence of glutathione is a very stable complexes of the type [Pt(dien)SG]+, which confirms 
the fact that the Pt-S(thiol) bond is the most stable. (Bose et al., 1995) The  Pt-S(thiol) bond 
can be terminated only in the presence of certain nucleophiles with sulphur, such as 
diethyldithiocarbamate, thiosulphate, thiourea. (Bugarčić et al., 2004a) Interesting is attempt 
to  hydrolysed Pt-S(GSH) bond in the presence of transition metal ions Cu(II) and Zn(II). 
(Cheng & Pai, 1998) 
2.2 Interaction of [Pt(terpy)Cl]+ complex with sulphur- and nitrogen-donor bio-
molecules 
In addition, [Pt(terpy)Cl]+ complex was also extensively studied. [Pt(terpy)Cl]+ complex has 
some biological activity. (Becker et al., 2001) In square-planar planes it contains tridentate-
coordinated terpyridine system (terpy = 2,2':6',2''-terpyridine), while the fourth coordination 
site occupies chloro ligand. 
Tridentate-coordinated terpyridine system, because of the presence of the aromatic pyridine 
unit and because of their bulkiness, strongly affects on the characteristics of this complex. In 
fact, [Pt(terpy)Cl]+  complex is much more reactive than complex with dien ligand. 
(Hofmann et al., 2003) The obtained values for lengths of chemical bonds between the 
platinum(II) and three nitrogen donor atoms of terpyridine system show that the shortest 
connection is to the secondary nitrogen atom. This feature is certainly reflected on its 
reactivity in the processes of substitution. In addition, the presence of electrostatic 
interactions between the pyridine units and metal ions has been observed in crystal 
structures of various Pt-terpy complexes. (Bailey et al., 1995)  
Although the high reactivity of the complex depend on the electronic interactions between 
the terpyridine system and Pt(II), (Hofmann et al., 2003)  bulkiness of the terpy ligand has 
great influence on the characteristics of this complex. The substitution reactions of the 
[Pt(terpy)Cl]+  complexes with different thioethers has been confirmed that there is no 
reaction, (Petrović B. et al., 1999; Bugarčić et al., 1997) which can be attributed to the strong 
steric effect. Although, the reactions of [Pt(terpy)Cl]+ complexes with some  
S-methyl-thioethers and thiones may occur, but in this case as the product of reactions 
appear dinuclear platinum complexes in which the bridge ligand is S-methyl-group. 
(Annibale et al., 1999) High reactivity of the [Pt(terpy)Cl]+ complex in substitution reactions 
with thiols is explained by formation of intramolecular hydrogen bonds between protons 
from the thiol-group and outgoing chloro ligand, which further stabilizes the transition 
state. (Annibale et al., 1998; Petrović B. et al., 1999; Bugarčić et al., 1997) 
In the reaction between biologically relevant ligands  and Pt(II) complexes, DNA fragments 
usually coordinated through the N7 atom to Pt(II). (Bugarčić et al., 2004b) Several products 
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of the reaction between [Pt(terpy)Cl]+  complex and DNA fragments were synthesized and 
characterized by X-ray analysis, in which the presence of strong intramolecular hydrogen 
bonds are observed. The role of these bonds are to further stabilizes the products of the 
reaction. (Wong & Lippard, 1977) 
The kinetics of the complex-formation reactions between [Pt(terpy)H2O]2+, with thiols: L-
cysteine, DL-penicillamine, GSH, and with thiourea were studied. (Bugarčić et al., 2002a) 
Rate constants and activation parameters derived from these experiments are summarized 
in Table 1. 
L k1298/M-1 s-1 H≠/kJ mol-1 S≠/J K-1 mol-1 ΔV≠/cm3 mol-1 
L-Cysteine 37.8 ± 0.1 25 ± 0.5 _132 ± 2 _9.3 ± 0.4 
L-Glutathione (5.8 ± 0.1)×102 23 ± 1 _116 ± 3 _12.4 ± 0.6 
DL-
Penicillamine 
12.8 ± 0.1 38 ± 1 _98 ± 3 _20.6 ± 1.0 
Thiourea (1.72 ± 0.02)×105 22 ± 1b _73 ± 1b _6.0 ± 0.3b 
aAll values refer to 0.10 M HClO4(Bugarčić et al., 2002a) b Data from  Jaganyi et al., 2001 
Table 1. Rate constants and activation parameters for the reaction of [Pt(terpy)H2O]2+ with 
thiols and thiourea. 
From Table 1. can be seen that although the thiol ligands are good entering groups for the 
Pt(II) complex, thiourea is the best nucleophile. From a comparison of the thiols used, it can 
be concluded that the variation in size, bulkiness and salvation of the entering ligands 
reflect in their properties as nucleophiles. The difference in nucleophilicity of the selected 
ligands is obvious and their reactivity follows the order; DL-penicillamine < L-cysteine < 
GSH < thiourea. The sensitivity of the reaction rate towards the σ-donor properties of the 
entering ligands is in line with that expected for an associative mode of activation. In 
addition, steric effects are very important as well. For example, DL-penicillamine has the 
lowest reactivity of the thiols used. This can be attributed to the steric effects involving the 
two methyl groups on carbon near the sulphur atom. At the same time, GSH is considerably 
more reactive than expected. This anomaly seems to suggest an appreciable anchimeric 
effect capable of reducing the activation energy of the substitution reaction, arising from 
hydrogen bonding interactions between the acidic group located in a suitable position of the 
nucleophile. The anchimeric effect has been reported for other reactions at Pt(II) complexes 
and is well known for organic reactions. (Wilkins, 1991) This clearly demonstrates that the 
versatile kinetic behaviour is controlled by steric hindrance on the tridentate ligand and the 
nucleophilicity of the entering nucleophiles. Increasing steric hindrance is expected to slow 
down the ligand substitution reactions, whereas increasing nucleophilicity is expected to 
speed up this process in terms of an associative mechanism.  
A trigonal bipyramidal transition state for reaction of [Pt(terpy)H2O]2+ with thiols, is 
probably stabilized by hydrogen bonding between the entering thiol and the leaving water 
ligand as already proposed for the reaction of [Pd(H2O)4]2+ with monodentate acetate, 
propionate, glycolate, and carboxylic acids (Shi & Elding, 1996, 1997) and for [Pt(H2O)4]2+ 
with thioglycolic acid. (Bugarčić & Đorđević, 1998) These findings indicate that bond-
making with the entering thiol is important in the activation process and that water is still 
tightly bound to the metal centre in the transition state. 
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Also, the reactions between [Pt(terpy)Cl]+ and thiols, such as GSH, L-cysteine,  
DL-penicillamine and thioglycolic acid have been studied. (Petrović B. et al., 1999) These 
thiols are very good entering groups for  Pt(II) complex. The reaction of the Pt(II) complex 
and DL-pencillamine is also the slowest one (Table 2.).  
The complex [Pt(terpy)Cl]+ appears to be more reactive than [Pt(dien)Cl]+ (Table 2.) in 
accordance with the greater possibility of π-interaction and π-trans effect probably operating 
as well. The Pt-N distance to the middle nitrogen atom of the terpyridine ligand, 1.930(4) A 
is slightly shorter than the distances of Pt to the other two nitrogen atoms, N1, 2.018(5) and 
N3 2.030(5). (Hofmann et al., 2003)   
 
 
k2/M-1s-1 
[Pt(dien)Cl]+ 
k2/M-1s-1 
[Pt(terpy)Cl]+ 
Thiglycolic acid 7.86 x 10-3 5.62 x 10-2 
L-Cysteine 1.43 x 10-3 1.06 x 10-2 
D-penicillamine 8.04 x 10-4 6.02 x 10-3 
Glutathione 3.85 x 10-3 7.77 x 10-2 
Table 2. The second-order rate constants for the reactions between thiols and Pt(II) 
complexes at T = 295 K. (Petrović B. et al., 1999) 
As in the case of [Pt(dien)H2O]2+, the kinetic data clearly show that 5’-GMP is more reactive 
to [Pt(terpy)H2O]2+ than either INO and 5’-IMP in 0.1 M NaClO4 and at pH = 2.5. (Bugarčić 
et al., 2004a) On the contrary, in the reactions of [Pd(SMC)(H2O)2]2+ with the same 
nucleophiles, (Bugarčić et al., 2002b) the most reactive one was INO, which can be attributed 
to a primary process that involves partial preassociation of the metal complex with the 
phosphate group in 5’-GMP and 5’-IMP. Furthermore, the pH at which antitumour 
complexes bind to DNA is significantly higher than used in this study. It is expected that at 
neutral pH the phosphate residue on the nucleotide will also bind to the central metal atom 
as a result of its deprotonation. (Jacobs et al., 1992) From a comparison of the reactivity of 
thiols (L-cysteine, DL-penicillamine and GSH) (Bugarčić et al., 2002a), with INO, 5’-IMP and 
5’-GMP in the reaction with [Pt(terpy)H2O]2+, it can be concluded that these N-bonding 
ligands are even better nucleophiles than the mentioned thiols. The preference of these  
N-bonding nucleophiles over thiols in acidic solutions needs to be addressed. It must be 
kept in mind that the reactions with thiols have been investigated at pH 1, where all thiols 
were protonated. On the other hand, at pH 2.5 the N7 sites of INO, 5’-IMP and 5’-GMP are 
not protonated. However, at or near neutral pH, although less than 10% of thiols are 
deprotonated, the N-bonding bases cannot compete with the thiol containing amino acids 
and peptides. (Bose et al., 1995;, Volckova et al., 2002) Therefore, binding primarily takes 
place through the sulphur donor sites. However, for the GSMe system, rapid coordination to 
the sulphur atom followed by migration to the N7 site of the purine was observed. (Teuben 
et al., 1977) Similar competition experiments of the bifunctional platinum complex, cis-
dichloro-(ethylendiamine)platinum(II) and its hydrolysed forms with a mixture of 5’-GMP 
or dGpG and thioether containing di- and tri-peptides, also afforded sulphur bound 
intermediates, followed by the formation of N7 coordinated guanine products. (Barnhham 
et al., 1996) 
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Several sulphur donor ligands are usually co-administered with platinum drugs to reduce 
the toxicity. (Chen et al., 1998; Berners-Price et al., 1996) Some of them, such as GSH, 
DEDTC, thiosulfate and thiourea, were used in the study with [Pt(terpy)(cyst-S)]2+ and 
[Pt(terpy)(gua-N7)]2+ complexes. (Bugarčić et al., 2004a) The X-ray structure of the 
[Pt(terpy)(cyst-S)]2+ and [Pt(terpy)(gua-N7)]2+ complexes were determinated. (Bugarčić et 
al., 2004a)  
The [Pt(terpy)(cyst-S)]2+ complex is unreactive toward nitrogen binding ligands and cysteine 
cannot be replaced by N7 from INO, 5’-IMP and 5’-GMP. However, very strong sulphur-
donor nucleophiles, such as DEDTC, thiosulfate and thiourea, could reverse the Pt–cysteine 
bond under pH ca. 6. (Bugarčić et al., 2004a)  This results clearly show that therapeutic 
nucleophilic agents for platinum drugs, such as DEDTC, thiosulfate and thiourea, may help 
to displace Pt from Pt–cysteine adducts and in that way could reduce nephrotoxicity.  
It is widely accepted that, once formed, the Pt–nucleobase complexes are inert under mild 
conditions and in the absence of strong trans-labilising ligands. (Lippert, 1999) In contrast, the 
presence of strong nucleophiles, for instance sulphur-containing bio-molecules, could facilitate 
the dissociation of N-coordinated nucleobases from the Pt(II) complex. In particular, various 
sulphur-containing molecules have aroused considerable interest owing to their important 
roles in the biological processing of anticancer platinum drugs. (Reedijk,1999) The substitution 
reactions of monofunctional [Pt(dien)(L-N7)]2+ (L = adenosine or guanosine) with thiourea 
have been studied in acidic aqueous solution. (Mikola et al., 1999) The substitution of 
guanosine from [Pt(terpy)(guo-N7)]2+ by some sulphur-donor nucleophiles which have been 
used as protecting agents were studied. (Bugarčić et al., 2004a) This result strongly indicate 
that all studied sulphur-donor nucleophiles could substitute guanosine from the Pt(II) 
complex. Also it is noticed that DEDTC and thiosulfate are the strongest nucleophiles and that 
these nucleophiles can very easily substitute guanosine from [Pt(terpy)(guo-N7)]2+. However, 
the tripeptide GSH is a very efficient nucleophile as well. This observation could be very 
important since it is already known that GSH has numerous cellular functions, including the 
detoxification of chemotherapeutic agents. However, GSH has been used as protecting agent 
and administered before or after cisplatin. (Reedijk, 1999) Cisplatin readily reacts with GSH 
and as much as 67% of the administered platinum has been found to coordinate to GSH. 
However, the role of GSH appears to be dual: GSH deactivates and activates cisplatin. 
(Volckova et al., 2002) The higher effectiveness of cisplatin has also been demonstrated by co-
administering cisplatin and GSH in patients. However, it is not clear whether this increase in 
effectiveness is due to the reduced toxicity or due to the modification of the platinum drug by 
binding to the metal. Currently there is much interest in the mechanisms responsible for the 
development of resistance. Such resistance is often associated with increased cellular GSH, 
consistent with the view that GSH protects cells against foreign compounds and the effects of 
radiation. (Jaganyi & Tiba, 2003) From our results we can conclude that the employed rescue 
or protecting agents such as thiourea, thiosulfate and DEDTC can much easier substitute 
guanosine than L-cysteine form the [Pt(terpy)X]2+ complex (X is guo-N7 or cyst-S). This is in 
excellent agreement with previous investigations, where has been shown that the Pt–S 
(cysteine) bond is very stable. (van Boom et al., 1999; Teuben et al., 2000;, Pitteri et al., 2001) 
The thiolate ion is capable of providing a stronger binding affinity owing to its better σ-
donating ability. Such a Pt–S bond is considered relatively inert may cause the inhibition of the 
anticancer activity of platinum drugs. 
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The kinetics for the complex formation of the [Pt(terpy)Cl]+ with 5’-GMP in the presence 
and absence of GSH at pH ca. 6, with a concentration ratio [Pt(terpy)Cl]+ : GSH : 5’-GMP = 
1 : 2 : 10 were studied. (Bugarčić et al., 2004b) The second order rate constants, obtained 
from linear least-squares analysis of the kinetic data (Bugarčić et al., 2004b) clearly point to a 
kinetic preference of [Pt(terpy)Cl]+ toward the GSH at pH ca. 6. 5’-GMP is also a very good 
nucleophile for Pt(II) complexes, but at neutral pH cannot compete with GSH. The second-
order rate constant for GSH is 102 times higher than for 5’-GMP. This is also reflected in the 
competition reactions utilizing mixtures of GSH and GMP. Also, proton and 195Pt NMR data 
did not show any N7 coordination of GMP, in spite of its excess, in the presence of thiols. 
(Teuben et al., 2000) However, at or near neutral pH, although less than 10% of thiols are 
deprotonated, the N-bonding bases cannot compete with the thiol containing amino acids 
and peptides. (Bugarčić et al., 2004a; Teuben et al., 2000) Therefore, binding primarily takes 
place through the sulphur donor sites. However, for the GSMe system, rapid coordination to 
the sulphur atom followed by migration to the N7 site of the purine was observed. (van 
Boom et al., 1999; Barnham et al., 1994) 
The progress of the reaction of [Pt(terpy)Cl]+ with other compounds over extended periods 
of time can be monitored with techniques such as HPLC which allows aliquots separated 
from the reaction mixture at programmed times to be analyzed. The studied reactions were 
carried out in water, without any buffer, since buffer ions (e.g. phosphate) are potential 
ligands for Pt(II). The pH of each solution was regularly checked over the reaction time, and 
was shown to be kept between 4.5 and 5.5. The products formed were isolated by reversed-
phase HPLC and characterized by MALDI-TOF mass spectrometry. As expected, the 
products obtained corresponded to the adducts [Pt(terpy)(GS)]+ and [Pt(terpy)(5’-GMP)]+ 
(m/z 734,2 and 789,8, respectively). The reaction between [Pt(terpy)Cl]+, GSH and 5’-GMP 
was then followed by HPLC. The ratio of the three compounds in the repeated assays was 
1:1:12, respectively. It was observed that [Pt(terpy)Cl]+ reacted much faster with GSH than 
with 5’-GMP, but this did not prevent a small amount (< 16%) of [Pt(terpy)(5’-GMP)]+ from 
being formed at the very beginning of the process. The relative proportion of this adduct 
remained virtually constant throughout the reaction process, which indicates that once 
formed it remains unaltered. The possibility that [Pt(terpy)(GS)]+ reactes with the excess of 
5’-GMP present in the reaction mixture to give [Pt(terpy)(5’-GMP)]+ can be ruled out, unless 
GSH can replace 5’-GMP from [Pt(terpy)(5’-GMP)]+ at the same reaction rate. The identity of 
the formed adducts was confirmed by mass spectrometric analysis of the products isolated 
from the reaction mixture by HPLC (Fig. 4.). (Bugarčić et al., 2004b) 
2.3 Interaction of [Pt(bpma)Cl]+ complex with sulphur- and nitrogen-donor  
bio-molecules 
In recent years, an intensive investigation of the substitution reactions of Pt(II) complexes 
which containing an inert tridentate nitrogen donor ligand with two or three pyridine units 
was performed. The role of these studies is to explain the effect of present pyridine on the 
reactivity of these compounds. For example, the complex [Pt(bpma)Cl]+, containes tridentate 
nitrogen donor ligand consisting of two pyridines connected via amide. 
This complex in substitution reactions react faster than the [Pt(dien)Cl]+ complex, but slower 
compared to [Pt(terpy)Cl]+ complex. The substitution reactions of this complex with thiols. 
(Jaganyi & Tiba, 2003) pyridine, derivatives of pyridine (Pitteri et al., 2001), 5’-GMP, azoles 
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and diazines (Bogojeski and Bugarčić, 2011) were studied. It is interesting that the aqua 
complex, [Pt(bpma)(H2O)]2+, which crystallizes with perchlorate as external ions, acts as a 
double base acid, because in the process of deprotonation the second stage involved 
coordinated amido group. (Pitteri et al., 2002) 
 
Fig. 4. HPLC profile of an aliquot of the reaction mixture [Pt(terpy)Cl]+/glutathione/5’-
GMP = 1:1:12 after 1 week reaction time.  
The substitution reactions of [Pt(bpma)Cl]+ and [Pt(bpma)(H2O)]2+ with L-methionine, GSH 
and 5’-GMP were studied. (Bugarčić et al., 2007) The reactions of the chloro complexes were 
followed in the presence of 10 mM NaCl and at pH ≈ 5, whereas the reactions of the aqua 
complexes were studied at pH 2.5.The nucleophilic attack of these ligands occurs via the 
sulphur donor of the thioether group in the case of L-methionine and of the thiol group in 
the case of GSH. L-methionine appears to be a better nucleophile than GSH under these 
experimental conditions. This could be explained by the positive inductive effect of the 
methyl group on the sulphur donor. (Bugarčić et al., 2007) 
Transformation from Pt–S(thioether) to Pt–N7(GMP) coordination seems to be common. 
(Reedijk, 1999; Soldatović & Bugarčić, 2005) To obtain more quantitative data for the 
stability differences between Pt–DNA and Pt–S(thioether) adducts, it was performed DFT 
calculations applying the model reaction (Eq. 1.) (L3 is terpy, bpma, dien, gly-met-S,N,N), 
where guanine approximates the guanosine-based interactions and SR2 represents a generic 
thioether: 
 [L3Pt-(N7-guanine)]2+  +  S(CH3)2                    [L3Pt-S(CH3)2]2+  +  guanine
    (1) 
In all cases guanine coordination to the L3Pt fragment is much more favored than thioether 
coordination. As shown in Table 3. 
The [Pt(bpma)Cl]+ and [Pt(bpma)(H2O)]2+ complexes are more reactive than [PtCl(gly-met-
S,N,N)] and [Pt(glymet-S,N,N)(H2O])+. This can be explained by the steric effect of the 
coordinated S–CH3 group in the cis position in [Pt(gly-met-S,N,N)(H2O)]+ and [PtCl(gly-
met-S,N,N)]. Moreover, another reason for the higher reactivity of the [Pt(bpma)(H2O])2+ 
and [Pt(bpma)Cl]+ complexes is the presence of two pyridine rings in the coordination 
sphere. This has been studied in detail for a set of monofunctional Pt(II) complexes with 
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tridentate ligands in which the number and position of the amine and pyridine groups were 
systematically varied. (Hofmann et al., 2003) The presence of π-acceptor ligands promotes 
the electrophilicity of the metal center and thereby the nucleophilic attack. (Hofmann et al., 
2003; Jaganyi et al., 2001) This behavior distinguishes these complexes from classic platinum 
drugs where such effects are not present. 
 
L3 B3LYP/LANL2DZp 
B3LYP(CPCM)/LANL2DZp// 
B3LYP/LANL2DZp 
terpy running  (ca. 27 kcal/mol) Still running kcal/mol 
bpma +28.7 kcal/mol +12.8 kcal/mol 
dien +34.1 kcal/mol +11.0 kcal/mol 
Gly-Met-N,N,S +21.5 kcal/mol   +9.5 kcal/mol 
Gly-Met-N,N,S 
(without H-bond) 
+17.5 kcal/mol   +8.5 kcal/mol 
Table 3. DFT results for model eq. (1) 
1H NMR spectroscopy was used to investigate the substitution reactions of the chloro 
complexes [Pt(bpma)Cl]+ and [PtCl(gly-met-S,N,N)] with 5’-GMP. The substitution reactions 
were studied in D2O at 298 K. (Bugarčić et al., 2007) 
The reaction of [PtCl(gly-met-S,N,N)] with 5’-GMP is approximately 50 times slower than 
the reactions of this complex with L-methionine or GSH. This could be accounted for in 
terms of steric effects of the incoming 5’-GMP and the complex as well. On the other hand, 
for the reactions with [Pt(bpma)Cl]+ the rate constants are of the same order of magnitude, 
but L-methionine is the best nucleophile and 5’-GMP is the poorest one. However, the 
[Pt(bpma)Cl]+ complex is much more reactive towards 5’-GMP than [PtCl(gly-met-S,N,N)]. 
(Bugarčić et al., 2007) This is in agreement with earlier published findings. (Volckova et al., 
2002,; Tauben et al., 2000) 
Substitution reactions of the complex [Pt(bpma)(H2O)]2+ with TU, DMTU and TMTU  Cl−, 
Br−, I− and SCN−, were studied in aqueous 0.10 M NaClO4 at pH 2.5. (Jaganyi et al., 2006) 
Based on the second order rate constants, k2, it can be concluded that the reactivity of the 
nucleophiles towards the complex follows the order: TMTU < TU < DMTU. The observed 
trend for the platinum complex was also reported earlier in the literature for the substitution 
reactions of the coordinated water molecule from [Pt(dien)(H2O)]2+, [Pt(terpy)(H2O)]2+ and 
[Pt(bpma)(H2O)]2+ complexes. (Shoukry et al., 1998; Bugarčić et al., 2004c) 
The observed trends can be attributed to the different structures (in terms of steric and 
inductive effects) of these three nucleophiles. The order of increasing steric hindrance for 
these nucleophiles is: TMTU < DMTU < TU. Theoretically, it would be expected that TU 
would react much faster than the other two nucleophiles. Instead, it turns out that DMTU is 
a much better nucleophile than TMTU and TU. This enhanced reactivity is due to the 
inductive effect introduced by the two methyl groups in the case of the DMTU, which over 
compensate the steric effect. (Jaganyi et al., 2006) 
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3. Interaction of bifunctional Pt(II) complexes with sulphur- and  
nitrogen-donor bio-molecules 
In order to achieve the best possible strategy in the designing of antitumor platinum 
complexes, it is necessary to know how mentioned compounds react with various sulfur- 
and nitrogen-donor bio-molecules. Significant information about these interactions were 
obtained from a number of studies implemented in vitro, among which are investigation of 
the substitution reactions of bifunctional  platinum complexes with various bio-molecules at 
different conditions. 
Cisplatin is most investigated bifunctional Pt(II) complex. (Redijk, 1999, 2009; Lippert, 
1999) In details has been described how cisplatin coordinate to a molecule of DNA. 
(Redijk, 1999, Lippert, 1999) In addition to investigate the interaction with the classical 
nucleoside (Barry et al., 2005; Anzellotti et al., 2005) The interactions with AMP, ADP and 
ATP were investigated, and the best reactivity toward Pt(II) complexes showed to be ATP. 
(Arpalahti  & Lehikoinen, 1990; Arpalahti & Lippert, 1990; Caradonna & Lippard, 1988; 
Bose et al., 1986; Martin, 1999) Also, the interactions of cisplatin with sulfur-donor bio-
molecules, L-cysteine, GSH, L-methionine were studied. GSH is more reactive than L-
cysteine. (Bugarčić et al., 2004a) In reactions with L-methionine, amino acid coordinates 
bidentate to platinum building S,N-chelate. If the amino acids is presented in excess the 
reaction may lead to the bidentate coordination of two molecules of amino acid for Pt(II)-
ion. (Norman et al., 1992) The competitive reaction between cisplatin, L-methionine and 
5'-GMP in the mixture were also examined. A predominant product is complex 
[Pt(NH3)2(N7-GMP)2], while compounds [Pt(N,L-methionine)(N7-GMP)(NH3)] and 
[Pt(N,L-methionine)2] are formed in a very small concentrations. (Kung et al., 2001) The 
competitive reactions between  5’-GMP and thiols were also studied, but only found 
product where is platinum coordinated to sulphur from thiols. (Volckova et al., 2002) The 
reactions of cisplatin with 5’-GMP and GSH were studied spectrophotometricaly at 37 oC. 
NMR technique was also applied to study the reactions of cisplatin with guanosine-5’- 
monophosphate. (Petrović D. et al., 2007) The rate constants for the reactions of cisplatin 
with 5’-GMP, obtained by 1H NMR experiments and obtained by Uv–Vis experiments, are 
in a good agreement. However, these results are in a good agreement with the published 
results. (Barnham et al., 1994) 
Fig. 5. show 1H NMR spectra of the reaction between cisplatin and 5’-GMP. The peak for the 
free 5’-GMP is at d 8.22 ppm, and for the product the peaks are at d 8.69 and at 8.71 ppm. 
The peak at 8.69 ppm is smaller than the peak at 8.71 ppm at the later stage of the reaction. 
(Petrović D. et al., 2007)  
During the reaction the peak at 8.71 ppm, which corresponds to the product, 
[Pt(NH3)2Cl(N7-GMP)]+, increased in intensity, while the peak for the free 5’-GMP (d 8.22 
ppm) decreased in intensity. At the end of the reaction all 5’-GMP is coordinated to Pt(II), 
and the peak for the free 5’-GMP disappears as shown in Fig. 5. 
The reactions of cisplatin with GSH were studied spectrophotometricaly, and it has been 
found that GSH is better nucleophile for cisplatin than 5’-GMP, (Petrović D. et al., 2007)  
what is also in agreement with previously published results. (Soldatović & Bugarčić, 2005; 
Hagrman et al., 2004) 
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Fig. 5. 1H HMR spectra of a solution of cisplatin (7.5 mM) and 5’-GMP (7.5 mM) in D2O at 
pH 7.4 and 298 K recorded as a function of time. 
Substitution reactions of the complexes cis-[Pt(NH3)2Cl2], [Pt(SMC)Cl2]–, [Pt(en)Cl2], and 
[Pt(dach)Cl2], with selected biologically important ligands, viz. 5’-GMP, L-histidine and 
1,2,4-triazole, were studied. (Bogojeski et al., 2010) All reactions were studied in aqueous  
25 mM Hepes buffer in the presence of 5 mM NaCl at pH = 7.2 under pseudo-first-order 
conditions as a function of concentration at 310 K by using Uv/Vis spectrophotometry. The 
substitution reactions were studied in the presence of 5 mM chloride to be close to the 
conditions in the cell where the concentration is ca. 4 mM. Two consecutive reaction steps, 
which both depend on the nucleophile concentration, were observed in all cases.  
The most reactive N-donor nucleophile is 1,2,4 triazole. L-Histidine has the same order of 
reactivity as 5’-GMP and it is only slightly faster than 5’-GMP. The difference in the 
reactivity of these nucleophiles can be accounted in terms of electronic and steric effects.  
5’-GMP is sterically more crowded than L-histidine and that can be the reason why the 
reactions with 5’-GMP are a bit slower. From a comparison of the values of the second-
order rate constants for the first reaction step, k2, it can be concluded that the order of 
reactivity of the complexes is:  [Pt(SMC)Cl2]–  > cis-[Pt(NH3)2Cl2] > [Pt(en)Cl2] > 
[Pt(dach)Cl2]. The high reactivity of [Pt(SMC)Cl2]– can be attributed to the strong trans-
labilization effect of the coordinated sulfur atom from the S-methyl-L-cysteine chelate. 
Such labilization has clearly been illustrated by an earlier study. (Bugarčić et al., 2004b) 
The reactivity of the complexes cis-[Pt(NH3)2Cl2], [Pt(en)Cl2] and [Pt(dach)Cl2] depends on 
steric effects. The [Pt(dach)Cl2] complex is the sterically most crowded one and the 
reactions are found to be slower than those with [Pt(en)Cl2] and cis-[Pt(NH3)2Cl2]. The 
reactions with [Pt(dach)Cl2] were expected to be slower than those with [Pt(en)Cl2], 
because the Pt(II) center should be less electrophilic due to the positive inductive effect of 
the cyclohexane ring. (Summa et al., 2006) The second step of the reaction are significantly 
slower than the reactions of the first step in all cases.  
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Transformation from Pt–S(thioether) to Pt–N7(GMP) coordination seems to be common in 
biological processes. (Reedijk, 1999; Soldatović & Bugarčić, 2005; Jansen et al., 2002; van 
Boom et al., 1999; Tauben et al., 2000; Barnham et al., 1996) We performed quantum 
chemical calculations to gain more insight into this process. To obtain more quantitative 
data for the difference in stability between Pt–DNA and Pt–S(thioether) adducts, DFT 
calculations were performed.  
In all cases guanine coordination to the fragments Pt(NH3)2, Pt(en) and Pt(dach) is much 
more favored than thioether coordination. For the first step in the gas phase Pt–N7(Gua) is 
more stable than Pt–S(thioether) by ca. 31–33 kcal/mol, and for the second step by 32–34 
kcal/mol.  
Finally, this result could be the first to clearly show how much the Pt–N7(Gua) adduct is 
more stable than the Pt–S(thioether) adduct. This is important since Pt–S(thioether) adducts 
have been postulated to be a drug reservoir for the binding of platinum to DNA, which may 
act as intermediates and then be transformed into Pt–N7(Gua) adduct. (Lippert, 1999;  
Reedijk, 1999; Jansen et al., 2002; van Boom et al., 1999;, Jung & Lippard, 2007) 
The kinetics and mechanism of ligand substitution reactions of [Pt(SMC)Cl2]  with 
biologically relevant ligands were studied as a function of chloride and nucleophile 
concentrations at pH 2.5 and 7.2. (Soldatović et al., 2009) It was observed that the slope and 
intercept obtained from the linear dependence of the observed rate constant on the 
nucleophile concentration strongly depend on the [Cl-] for all the studied substitution 
reactions. At high [Cl-], the rate constant for the forward reaction is almost zero and that for 
the back reaction follows the order: L-methionine > GSH ~ INO > 5’-GMP. Ion-pair 
formation between the positively charged Pt(II) complex and the chloride ion is suggested to 
account for the saturation kinetics observed for the back reaction. 
At the highest [Cl-] of 0.1 M the binding of the nucleophiles is drastically slowed down and 
almost completely suppressed. This will be the case during the transport of such anti-
tumour complexes in blood. At low chloride concentrations as found in cells, effective 
binding of the studied nucleophiles will occur. The order of reactivity L-met > GSH ~ INO > 
5’-GMP clearly shows the high affinity of the Pt(II) complex for thioether. These interactions 
are more favourable because the transformation from Pt–S(thioether) to Pt–N7 coordination 
was observed. (Soldatović & Bugarčić, 2005) In our earlier work we did not observe any 
measurable transformation from Pt–S(thiol) to Pt–N7 coordination. (Bugarčić et al., 2004b) 
The lower reactivity of 5’-GMP compared to INO can be explained by the fact that at pH 2.5 
the N7 position of inosine is almost fully deprotonated whereas in 5’-GMP it is still partially 
protonated (N7 pKa = 2.33). (Bugarčić et al., 2004b)  At pH = 7.2, it is possible that the 5’-
monophosphate residue of the nucleotide (pKa a 6) binds to the metal center, which can lead 
to additional complications in the complex-formation at higher pH and slower second-order 
rate constants are obtained. 
A set of three oxaliplatin derivatives containing 1,2-trans-R,R-diaminocyclohexane (dach) as 
a spectator ligand and different chelating leaving groups X–Y, viz., [Pt(dach)(O,O-
cyclobutane-1,1-dicarboxylate)], or Pt(dach)(CBDCA), [Pt(dach)(N,O-glycine)]+, or 
Pt(dach)(gly), and [Pt(dach)(N,L-methioninehionine)]+, or Pt(dach)(L-Met), where L-Met is  
L-methionine, were synthesized and the crystal structure of Pt(dach)(gly) was determined 
by X-ray diffraction. (Summa et al., 2007) The effect of the leaving group on the reactivity of 
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the resulting Pt(II) complexes was studied for the nucleophiles thiourea, GSH and L-Met 
under pseudo-first-order conditions as a function of nucleophile concentration and 
temperature, using Uv–Vis spectrophotometric techniques. 1H NMR spectroscopy was used 
to follow the substitution of the leaving group by guanosine 5’-monophosphate (5’-GMP2–). 
The rate constants for all reactions of direct substitution of the X–Y chelate by the selected 
nucleophiles, showing that the nature of the  chelate, viz., O–O (CBDCA2–), N–O (glycine) or 
S–N(L-Met), respectively, plays an important role in the kinetic and mechanistic behavior of 
the Pt(II) complex.  
The nature of the chelate, being O–O(CBDCA2–), N–O(glycine) or S–N(L-Met) was shown to 
play an important role in the kinetic and mechanistic behavior of the Pt(II) complexes. 
Pt(dach)(CBDCA) exhibits a higher reactivity towards the sulfur donor L-Met than 
Pt(dach)(gly), whereas the order is the opposite for the nitrogen donor 5’-GMP2– and the 
sulfur donors thiourea and GSH in the first reaction step. The Pt–N bond was always found 
to be very strong, especially for the reaction with 5’-GMP2–, in which the 1:1 reaction 
product [Pt(N-gly)(N7-GMP)] is very stable and hardly (7%) reacts with another molecule of 
5’-GMP2– to form the 1:2 product. By contrast, the liberation of H2CBDCA in 
Pt(dach)(CBDCA) in the second reaction step was faster than the rate-determining first 
reaction step and could not be analyzed under the selected experimental conditions. The 
mechanism of the substitution reactions is associative as supported by the large and 
negative values of ΔS#. 
Multinuclear complexes of platinum(II) represent a third generation of antitumor drugs as 
and platinum(IV) complexes. (Esposito & Najjar, 2002) The reason for the increasing interest 
in multinuclear complexes is their ability to form DNA adducts that differ significantly from 
those formed cisplatin and related complexes, (McGregor et al., 1999) which results in a 
completely different anti tumor behaviour. The biological activity of polynuclear platinum 
complexes maybe modulated by the geometry and number of leaving groups in the 
coordination sphere of platinum atoms as well as by the nature of linkers connecting the 
platinum centers. In contrast with the mononuclear complexes, such as antitumor cisplatin 
and clinically ineffective transplatin, in the dinuclear case both geometries are antitumor 
active. (Farrell, 2004)  
We compared the cytotoxic capacity of platinum complexes (Fig. 6.) towards TOV21G, HCT 
116 tumour human cell lines and human MSC, normal rapidly dividing cells (Fig. 7.). 
(Jovanović et al., 2011) 
All complexes displayed a dose-dependent and time-dependent cytotoxicity towards the 
tested cell lines but the most cytotoxic effect showed towards TOV21G cells (Fig. 7). The 
complex [PtCl4(dach)] at the lower concentrations induced significantly higher cytotoxic 
effect towards TOV21G cells then other four complexes.  
HCT116 cells were more resistant to the cytotoxic effects of selected complexes (Fig. 7). 
Again, [PtCl4(dach)] was the most efficient and exerted very similar activity towards 
HCT116 cells as cisplatin.  
The complexes Pt2 and Pt3 displayed cytotoxicity towards MSC similar as cisplatin, but the 
other three complexes Pt1, [PtCl4(dach)] and [PtCl4(bipy)] were more toxic. (Jovanović et al., 
2011) 
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Fig. 6.  Structures of investigated dinuclear platinum(II) complexes. 
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Fig. 7. Cytotoxic activity of tested complexes measured by MTT test (Mean+/-SE).  
4. Conclusion 
Results presented here, could contribute to a better understanding of the precise 
biochemical mechanism of some Pt(II) complexes. Moreover, the results of the substitution 
reactions with biologically relevant ligands could help to get more information on the 
possible interaction modes of Pt(II) complexes with in vivo targets and their representative 
application in the study of their anti-tumour properties. Detailed knowledge of the 
interactions between transition metal ions complexes with biomolecules and stability of final 
products under varying experimental conditions is fundamental for future investigations of 
new pharmacological agents and discovery of the alternative tumor treatment. Connecting 
theoretical calculations, chemistry, biochemistry and cellular biology and establishement of 
the structure-activity relationship Pt(II) complexes will help to solve some of the questions 
and will finally result in more tailored drug design. Numerous data imply that interactions 
of Pt(II) complexes and investigation of the mechanism of their reaction with DNA 
fragments (purine and pyrimidine bases, as well as oligonucleotides) are important for 
antitumor activity of Pt(II) complexes and the results of studies presented above contribute 
to that. Investigations of the interaction of Pt(II) complexes with other  
S-donor biomolecules can help us to get better insights in the destiny of anti-tumor drugs in 
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the cells after their uptake, as well as to obtain more information about the inner cellular 
processes, which are affected by therapy.  
Further research in this area will be based on the synthesis and investigation of the 
substitution reactions of the transition metals complexes especially Pt(II), Pt(IV), Au(III) and 
Ru(II/III) complexes. This complexes are investigated in order to find compounds that 
would demonstrate greater anti-tumour activity and less toxicity and resistance compared 
to cisplatin. It turned out that some complexes of Pt(IV) are toxic to cancers where cisplatin 
developed resistance. A good feature of the complexes of Pt(IV) is that some of them can be 
taken orally. When the complex of Pt(IV) enters the cell, it leads to the reduction of Pt(IV) to 
Pt(II) and binding to DNA. Au(III) is isoelectronic with Pt(II) and forms square planar 
complexes, and is therefore a good candidate for the synthesis of new complexes that could 
show better properties than the complexes of Pt(II). Also, complexes of Ru(II/III) are 
potential anti-cancer agents and consequently the study of these complexes is of great 
importance. 
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